Loss in MCL-1 function sensitizes non-Hodgkin's lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199)
MCL-1 功能丧失使非霍奇金淋巴瘤细胞系对 BCL-2 选择性抑制剂维奈克拉 (ABT-199) 敏感
期刊:Blood Cancer Journal
影响因子:12.9
doi:10.1038/bcj.2015.88
D C Phillips, Y Xiao, L T Lam, E Litvinovich, L Roberts-Rapp, A J Souers, J D Leverson
